News from the department of Pharmacology-Toxicology
Latest entry in the department of Pharmacology-Toxicology:
Lecanemab
Lecanemab Definition Lecanemab is the first anti-amyloid antibody that causally targets the causes of Alzheimer's disease and is intended to remove beta-amyloid protein deposits from the brain, thereby improving cognitive symptoms and slowing the progression and deterioration of quality of life.A...
Go to articleRecent search terms:
70,266
Articles
181,006
Sections
17,174
Images
Prof. Dr. med. Peter Altmeyer
Editor-in-Chief
One of Germany's most accomplished dermatologists with decades of expertise in clinical dermatology. Emeritus professor at the Ruhr-Universität Bochum, author of more than 30 textbooks and over 700 scientific publications.